{"DataElement":{"publicId":"6063731","version":"1","preferredName":"TP53 Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of TP53 gene mutant protein identified.","longName":"TP53_mutation","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6063515","version":"1","preferredName":"TP53 Gene Mutant Protein Identification","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity._A protein with an amino acid sequence that differs from the wildtype, canonical sequence._The procedure of having an identity established.","longName":"6062586v1.0:6101599v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6062586","version":"1","preferredName":"TP53 Gene","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","longName":"C17359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491F8B8-6A9A-1478-E053-F662850AC96F","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6101599","version":"1","preferredName":"Mutant Protein Identification","preferredDefinition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.:The procedure of having an identity established.","longName":"C147118:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ABA3FA-C72E-36DE-E053-F662850A178D","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A46AFA-BF67-53E4-E053-F662850A43EA","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6063677","version":"1","preferredName":"TP53 Protein Variant Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6063677v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"2770998","version":"1","preferredName":"Specify Other","longName":"2770998","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F45DBF-5E42-1D6F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-08-08","modifiedBy":"COOPERM","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33DD-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R282G","valueDescription":"TP53 NP_000537.3:p.R282G","ValueMeaning":{"publicId":"6063678","version":"1","preferredName":"TP53 NP_000537.3:p.R282G","longName":"6063678","preferredDefinition":"A change in the amino acid residue at position 282 in the cellular tumor antigen p53 protein where arginine has been replaced by glycine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R282G","conceptCode":"C146925","definition":"A change in the amino acid residue at position 282 in the cellular tumor antigen p53 protein where arginine has been replaced by glycine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-33E7-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3400-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R282W","valueDescription":"TP53 NP_000537.3:p.R282W ","ValueMeaning":{"publicId":"6063679","version":"1","preferredName":"TP53 NP_000537.3:p.R282W ","longName":"6063679","preferredDefinition":"A change in the amino acid residue at position 282 in the cellular tumor antigen p53 protein where arginine has been replaced by tryptophan.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R282W","conceptCode":"C146923","definition":"A change in the amino acid residue at position 282 in the cellular tumor antigen p53 protein where arginine has been replaced by tryptophan.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-340A-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3423-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R273L","valueDescription":"TP53 NP_000537.3:p.R273L","ValueMeaning":{"publicId":"6063680","version":"1","preferredName":"TP53 NP_000537.3:p.R273L","longName":"6063680","preferredDefinition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by leucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R273L","conceptCode":"C146920","definition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by leucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-342D-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3446-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R273C","valueDescription":"TP53 NP_000537.3:p.R273C","ValueMeaning":{"publicId":"6063681","version":"1","preferredName":"TP53 NP_000537.3:p.R273C","longName":"6063681","preferredDefinition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by cysteine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R273C","conceptCode":"C146917","definition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by cysteine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3450-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3469-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R273H","valueDescription":"TP53 NP_000537.3:p.R273H","ValueMeaning":{"publicId":"6063682","version":"1","preferredName":"TP53 NP_000537.3:p.R273H","longName":"6063682","preferredDefinition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by histidine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R273H","conceptCode":"C146915","definition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by histidine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3473-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-348C-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"V272M","valueDescription":"TP53 NP_000537.3:p.V272M ","ValueMeaning":{"publicId":"6063683","version":"1","preferredName":"TP53 NP_000537.3:p.V272M ","longName":"6063683","preferredDefinition":"A change in the amino acid residue at position 272 in the cellular tumor antigen p53 protein where valine has been replaced by methionine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.V272M","conceptCode":"C146913","definition":"A change in the amino acid residue at position 272 in the cellular tumor antigen p53 protein where valine has been replaced by methionine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3496-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-34AF-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"G266E","valueDescription":"TP53 NP_000537.3:p.G266E","ValueMeaning":{"publicId":"6063684","version":"1","preferredName":"TP53 NP_000537.3:p.G266E","longName":"6063684","preferredDefinition":"A change in the amino acid residue at position 266 in the cellular tumor antigen p53 protein where glycine has been replaced by glutamic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.G266E","conceptCode":"C146910","definition":"A change in the amino acid residue at position 266 in the cellular tumor antigen p53 protein where glycine has been replaced by glutamic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-34B9-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-34D2-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"G266V","valueDescription":"TP53 NP_000537.3:p.G266V","ValueMeaning":{"publicId":"6063685","version":"1","preferredName":"TP53 NP_000537.3:p.G266V","longName":"6063685","preferredDefinition":"A change in the amino acid residue at position 266 in the cellular tumor antigen p53 protein where glycine has been replaced by valine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.G266V","conceptCode":"C146908","definition":"A change in the amino acid residue at position 266 in the cellular tumor antigen p53 protein where glycine has been replaced by valine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-34DC-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-34F5-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R248W","valueDescription":"TP53 NP_000537.3:p.R248W","ValueMeaning":{"publicId":"6063686","version":"1","preferredName":"TP53 NP_000537.3:p.R248W","longName":"6063686","preferredDefinition":"A change in the amino acid residue at position 248 in the cellular tumor antigen p53 protein where arginine has been replaced by tryptophan.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R248W","conceptCode":"C146906","definition":"A change in the amino acid residue at position 248 in the cellular tumor antigen p53 protein where arginine has been replaced by tryptophan.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-34FF-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3518-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R248Q","valueDescription":"TP53 NP_000537.3:p.R248Q ","ValueMeaning":{"publicId":"6063687","version":"1","preferredName":"TP53 NP_000537.3:p.R248Q ","longName":"6063687","preferredDefinition":"A change in the amino acid residue at position 248 in the cellular tumor antigen p53 protein where arginine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R248Q","conceptCode":"C146903","definition":"A change in the amino acid residue at position 248 in the cellular tumor antigen p53 protein where arginine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3522-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-353B-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"G245D","valueDescription":"TP53 NP_000537.3:p.G245D","ValueMeaning":{"publicId":"6063688","version":"1","preferredName":"TP53 NP_000537.3:p.G245D","longName":"6063688","preferredDefinition":"A change in the amino acid residue at position 245 in the cellular tumor antigen p53 protein where glycine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.G245D","conceptCode":"C146900","definition":"A change in the amino acid residue at position 245 in the cellular tumor antigen p53 protein where glycine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3545-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-355E-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"G245S","valueDescription":"TP53 NP_000537.3:p.G245S","ValueMeaning":{"publicId":"6063689","version":"1","preferredName":"TP53 NP_000537.3:p.G245S","longName":"6063689","preferredDefinition":"A change in the amino acid residue at position 245 in the cellular tumor antigen p53 protein where glycine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.G245S","conceptCode":"C146896","definition":"A change in the amino acid residue at position 245 in the cellular tumor antigen p53 protein where glycine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-3568-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-3581-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"C238Y","valueDescription":"TP53 NP_000537.3:p.C238Y","ValueMeaning":{"publicId":"6063690","version":"1","preferredName":"TP53 NP_000537.3:p.C238Y","longName":"6063690","preferredDefinition":"A change in the amino acid residue at position 238 in the cellular tumor antigen p53 protein where cysteine has been replaced by tyrosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.C238Y","conceptCode":"C146892","definition":"A change in the amino acid residue at position 238 in the cellular tumor antigen p53 protein where cysteine has been replaced by tyrosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-358B-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-35A4-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Y220C","valueDescription":"TP53 NP_000537.3:p.Y220C","ValueMeaning":{"publicId":"6063691","version":"1","preferredName":"TP53 NP_000537.3:p.Y220C","longName":"6063691","preferredDefinition":"A change in the amino acid residue at position 220 in the cellular tumor antigen p53 protein where tyrosine has been replaced by cysteine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.Y220C","conceptCode":"C146890","definition":"A change in the amino acid residue at position 220 in the cellular tumor antigen p53 protein where tyrosine has been replaced by cysteine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-35AE-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COLBERTM","dateModified":"2021-01-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-35C7-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R213L","valueDescription":"TP53 NP_000537.3:p.R213L","ValueMeaning":{"publicId":"6063692","version":"1","preferredName":"TP53 NP_000537.3:p.R213L","longName":"6063692","preferredDefinition":"A change in the amino acid residue at position 213 in the cellular tumor antigen p53 protein where arginine has been replaced by leucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R213L","conceptCode":"C146888","definition":"A change in the amino acid residue at position 213 in the cellular tumor antigen p53 protein where arginine has been replaced by leucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-35D1-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COLBERTM","dateModified":"2020-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-35EA-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R175H","valueDescription":"TP53 NP_000537.3:p.R175H","ValueMeaning":{"publicId":"6063693","version":"1","preferredName":"TP53 NP_000537.3:p.R175H","longName":"6063693","preferredDefinition":"A change in the amino acid residue at position 175 in the cellular tumor antigen p53 protein where arginine has been replaced by histidine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R175H","conceptCode":"C146886","definition":"A change in the amino acid residue at position 175 in the cellular tumor antigen p53 protein where arginine has been replaced by histidine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-35F4-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-360D-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"R175C","valueDescription":"R175C","ValueMeaning":{"publicId":"7024275","version":"1","preferredName":"R175C","longName":"7024275","preferredDefinition":"A change in the amino acid residue at position 175 in the cellular tumor antigen p53 protein where arginine has been replaced by cysteine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R175C","conceptCode":"C165579","definition":"A change in the amino acid residue at position 175 in the cellular tumor antigen p53 protein where arginine has been replaced by cysteine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9597B9EA-B13E-7F7F-E053-F662850AB6AA","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9597B9EA-B157-7F7F-E053-F662850AB6AA","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"},{"value":"R273S","valueDescription":"R273S","ValueMeaning":{"publicId":"7024276","version":"1","preferredName":"R273S","longName":"7024276","preferredDefinition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 NP_000537.3:p.R273S","conceptCode":"C165581","definition":"A change in the amino acid residue at position 273 in the cellular tumor antigen p53 protein where arginine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9597B9EA-B161-7F7F-E053-F662850AB6AA","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9597B9EA-B17A-7F7F-E053-F662850AB6AA","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA7615-33C5-3AB1-E053-F662850A7528","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000448","version":"1","longName":"Melanoma","context":"OCG"},{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"},{"publicId":"7026248","version":"1","longName":"Endometrial","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If TP53 mutation identified,","type":"Preferred Question Text","description":"If TP53 mutation identified, which one?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC5B07-1A76-7628-E053-F662850AA377","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}